At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IMRA Bitwise MARA Option Income Strategy ETF
Pre-Mkt 03-03 09:28:41 EST
14.89
+0.14
+0.95%
High15.00Low13.84Vol3.75K
Open13.84D1 Closing14.75Amplitude7.88%
Mkt Cap2.68MTradable Cap2.68MTotal Shares180.00K
T/O55.06KT/O Rate2.08%Tradable Shares180.00K
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Why MARA Holdings Is Breaking from Bitcoin’s Price Action
TIPRANKS  ·  17:05
Why MARA Holdings Is Breaking from Bitcoin’s Price Action
Proshares Bitcoin Strategy ETF up 4.7%, Ishares Bitcoin Trust up 4.6%
THOMSON REUTERS  ·  03-02 23:22
Proshares Bitcoin Strategy ETF up 4.7%, Ishares Bitcoin Trust up 4.6%
Riot Platforms up 2.2%, Hut 8 up 4.1%, Mara Holdings up 5.4%
THOMSON REUTERS  ·  03-02 23:22
Riot Platforms up 2.2%, Hut 8 up 4.1%, Mara Holdings up 5.4%
Crypto-Related Stocks Rise as Bitcoin Climbs 4.5%
THOMSON REUTERS  ·  03-02 23:22
Crypto-Related Stocks Rise as Bitcoin Climbs 4.5%
Dagang NeXchange, MARA to Support Start-Ups, Digital Development
MT Newswires Live  ·  03-02 16:56
Dagang NeXchange, MARA to Support Start-Ups, Digital Development
MARA Holdings Surges as Bold AI Pivot Splits Wall Street
TIPRANKS  ·  02-28
MARA Holdings Surges as Bold AI Pivot Splits Wall Street
MARA, Starwood and the New HPC Bet Trending
TIPRANKS  ·  02-28
MARA, Starwood and the New HPC Bet Trending
Bitcoin Miner MARA Pivots To AI After $1.7 Billion Loss As Stock Surges 10%
Benzinga  ·  02-28
Bitcoin Miner MARA Pivots To AI After $1.7 Billion Loss As Stock Surges 10%
BUZZ-U.S. STOCKS ON THE MOVE-Oil companies, Arlo Technologies, AES
Reuters  ·  02-28
BUZZ-U.S. STOCKS ON THE MOVE-Oil companies, Arlo Technologies, AES
Mara Holdings downgraded at H.C. Wainwright on bitcoin forecast, execution risk
TIPRANKS  ·  02-28
Mara Holdings downgraded at H.C. Wainwright on bitcoin forecast, execution risk
Mara Holdings, Inc. : H.c. Wainwright Cuts to Neutral From Buy
THOMSON REUTERS  ·  02-27
Mara Holdings, Inc. : H.c. Wainwright Cuts to Neutral From Buy
Mara Holdings downgraded to Neutral from Buy at H.C. Wainwright
TIPRANKS  ·  02-27
Mara Holdings downgraded to Neutral from Buy at H.C. Wainwright
Mara Holdings price target lowered to $11 from $21 at Cantor Fitzgerald
TIPRANKS  ·  02-27
Mara Holdings price target lowered to $11 from $21 at Cantor Fitzgerald
MARA Holdings Is Maintained at Overweight by Cantor Fitzgerald
Dow Jones  ·  02-27
MARA Holdings Is Maintained at Overweight by Cantor Fitzgerald
MARA Surges 13% After Earnings, Starwood Infrastructure Deal
Benzinga  ·  02-27
MARA Surges 13% After Earnings, Starwood Infrastructure Deal
Fred Thiel Says MARA Holdings Will Leverage Bitcoin Holdings For 'Financial Flexibility' As Firm Pivots Beyond Pure-Play Mining
Benzinga  ·  02-27
Fred Thiel Says MARA Holdings Will Leverage Bitcoin Holdings For 'Financial Flexibility' As Firm Pivots Beyond Pure-Play Mining
Mara Holdings Shares up 16% Premarket After Co Partners With Starwood to Build AI Data Centers
THOMSON REUTERS  ·  02-27
Mara Holdings Shares up 16% Premarket After Co Partners With Starwood to Build AI Data Centers
MARA Holdings Shares Surge After-Hours on AI Infrastructure Venture with Starwood Capital
Stock News  ·  02-27
MARA Holdings Shares Surge After-Hours on AI Infrastructure Venture with Starwood Capital
MARA Stock Jumps 16% Despite Q4 Miss on Expansion Plans into AI, High-Performance Compute
Tiger Newspress  ·  02-27
MARA Stock Jumps 16% Despite Q4 Miss on Expansion Plans into AI, High-Performance Compute
MARA Holdings, Starwood Partner on U.S. Bitcoin Data Centers
TIPRANKS  ·  02-27
MARA Holdings, Starwood Partner on U.S. Bitcoin Data Centers

Introduction

Company Name.
Bitwise MARA Option Income Strategy ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Issue price:
--